Meeting
2016 ASCO Annual Meeting
Adverse impact of polypharmacy and potentially inappropriate medication use in newly diagnosed, elderly lymphoma patients.
Authors
Richard Jirui Lin
NYU Langone Medical Center, New York, NY
Richard Jirui Lin , Robin Guo , Daniel Jacob Becker , Michael L. Grossbard , Catherine S. Magid Diefenbach
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality of Care
Track
Health Services Research and Quality of Care
Sub Track
Outcomes
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6562)
DOI
10.1200/JCO.2016.34.15_suppl.6562
Abstract #
6562
Poster Bd #
49
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Polypharmacy and potentially inappropriate medication use in older patients with aggressive non-Hodgkin lymphoma (NHL) leads to inferior survival and increased treatment-related toxicities.
First Author: Richard Jirui Lin
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.
First Author: Richard Jirui Lin
Poster
2021 ASCO Annual Meeting
Survival outcomes, treatment toxicity, and healthcare utilization in older adults with aggressive non-Hodgkin lymphoma (NHL).
First Author: Mitchell W. Lavoie
Poster
2024 ASCO Annual Meeting
Zotiraciclib for newly diagnosed or recurrent glioblastoma: Updated outcome and biomarker analysis.
First Author: Michael Weller